New York A 10475: Requires the Superintendent of Financial Services to refer the drug insulin to the Drug Accountability Board for examination related to price increases and consumer impact

Status: REFERRED TO RULES (as of 2022-06-03)

State: New York · Session: 2021-2022 · Bill: A 10475

Sponsors: Rules Committee

View New York A 10475 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.